Although low-cost trading platform SelfWealth (ASX: SWF) has seen customers reduce their online trading activity, many opting for rival platforms that are even cheaper, there is a silver lining amid rising interest rates where the Company is accruing more revenue as interest through the $736 million they hold as cash on behalf of their customers.
Read More
If you are sitting at a poker table, Tony Fung is the chip leader with pocket aces that just checked on the river. As the majority shareholder, he’s stoked to see Aquis Entertainment (ASX: AQS) throw away $1 million to secure much more by accepting a rival offer for Canberra Casino where a new buyer
Read More
“A looming eye health crisis” – these are the words used to describe the situation many Aussies will face if adequate investment is not made over the next five years, according to the peak professional body for optometrists in Australia. Optometry Australia is calling on the nation’s major political parties to take vision problems more
Read More
While small cap shareholders have become accustomed to major share price gains once a medtech or biotech receives FDA approval to commercialise their products, it’s not all sunshine and rainbows on the FDA horizon as Lumos Diagnostics (ASX: LDX) has found, following the rejection of their FebriDx test kits. As a rapid diagnostic test that
Read More
Like how learning is often compared to the process of osmosis, education tech company Janison Education Group (ASX: JAN) is dispersing its way into some well known adult education institutions with several enterprise contract wins leading to the company setting new revenue records in FY22. Enterprise clients remain the softest target for Janison where online
Read More
The cheers of the cannabis industry can be heard loud and clear as the demand for the plant continues to prop up their profits. The last few years have been huge for the industry as companies attempt to strengthen earnings by out-scaling competitors. One company hoping to come out on top is Althea Group (ASX:
Read More
Autism Spectrum Disorder (ASD) affects 1 in 150 Australians. Boys are 4 times more likely to have it than girls, and symptoms are noticeable at around 2-3 years of age. According to the Australian Institute of Health and Welfare, the number of people with ASD in Australia is increasing, providing an impetus for biopharmaceutical company
Read More
With improvements in allied healthcare, the 134 million people worldwide diagnosed with glaucoma is likely to increase with better diagnostics, but also ensure earlier detection which can be treated sooner as evidenced by medtech company Nova Eye Medical (ASX: EYE) and rising sales of their advanced ophthalmic treatment technologies and devices. As the developers and
Read More
“Fine” said Mr Burns as he emptied his wallet, sending cash and credit cards tumbling into the money basket of Springfield Church. Usually a shyster of the first order, Burns felt that this was the only reasonable course of action after having been repeatedly prodded and pushed with the basket. His fellow churchgoers, having already
Read More
An Australian beer rapidly rising in popularity as a low-carb alternative is set to be launched in New Zealand with alcoholic drinks brewer Mighty Craft (ASX: MCL) entering into an agreement with DB Breweries to distribute Better Beer in New Zealand. The binding agreement will see the zero-carb, zero-sugar and low-calorie beer initially imported into
Read More
